preloader
preloader
Polaris Component — Value & Market Access Intelligence

Value AI

Evidence-backed market access for MedTech and pharma suppliers. Agentic AI, powered by Polaris, that keeps your evidence current, tracks policy and HTA change, and links every value claim to its proof.

Book A Demo ↗
Evidence Desk — EMEA Portfolio Tracking
2,480
Evidence assets indexed
640
Claims traced to proof
27
Policy & HTA signals this week
18
Dossiers submission-ready
Signal feed
Claims with current proof — 12 months
Illustrative interface and figures, shown for design purposes.
Why now

Every claim needs a proof chain.

Buyers score value, not just price, and HTA bodies ask for substantiation. A claim backed by last year's evidence, or by nothing at all, is a market access risk. Value AI links every claim to current, approved proof before anyone asks.

Claims Evidence Clinical outcome claimdossier · section 3 Cost-effectiveness claimbid response · lot 2 Total cost of care claimvalue story · DE Sustainability claimESG criterion · contract Clinical studyapproved · v4 Health-economic modelapproved · v2 Real-world evidenceapproved · registry Cost-of-care analysisapproved · v3 evidence expired caught before submission
7.3%
average ESG weighting in European MedTech contracts in 2022, up from under 5% in 2020.Source: Vamstar analysis of 15,000+ contract documents for MedTech Europe
Claims without current proof
Evidence ages, gets superseded or was never attached. Value AI flags it before a reviewer does.
Dossiers out of step with policy
HTA and reimbursement rules move. Dossiers that don't move with them quietly lose access.

Every claim linked to its proof, with provenance, approval state and change history, so value stands up wherever it is tested.

Defensible by design. Know what was submitted, when, and why, in every market, for every claim.

The mechanism

Gather. Watch. Prove. Package.

One continuous market access system, from scattered evidence to a submission-ready value dossier. Each stage feeds the next; every claim keeps its proof.

01.[ Gather Module ]
Evidence Intelligence Engine

Value AI consolidates clinical, economic and outcomes assets into a structured evidence layer. Polaris classifies documents, extracts key endpoints, and keeps artifacts versioned and permissioned. Teams stop hunting across shared drives and start working from a single evidence baseline that is current, searchable and ready for reuse across markets.

Output: Single evidence baseline
  • Clinical studies and outcomes data
  • Health-economic models
  • Real-world evidence
  • Sustainability and ESG reports
Polaris classifies each document and extracts the endpoints that matter, so evidence is searchable by what it proves rather than where it is filed.
Every artifact carries its version, owner and permissions. Teams always work from the current approved evidence, never a stale copy.
Evidence Classification by Polaris OS
Single Evidence Baseline
02.[ Watch Module ]
Policy & HTA Tracking Engine

Value AI monitors policy shifts, HTA signals and procurement scoring changes that impact access and contract eligibility. Polaris normalizes updates into a consistent taxonomy so teams can spot what changed, where it matters, and which dossiers need a refresh.

Output: Dossiers flagged for refresh
HTA signals · policy updates
Procurement scoring changes
Policy Normalization by Polaris OS
Health technology assessment guidance and decisions tracked market by market, mapped to the products and dossiers they affect.
  • Reimbursement and pricing rule changes
  • National and regional policy updates
  • One consistent taxonomy across markets
  • What changed, where, and why it matters
Shifts in contract award criteria and weighting, including value-based and ESG scoring, surfaced before they cost you a bid.
Dossiers Flagged for Refresh
03.[ Prove Module ]
Claims-to-Evidence Traceability Engine

Value AI links every claim to its supporting proof, with clear provenance and approval state. Polaris maintains traceability from narrative to citation to artifact, reducing risk when bids, market access submissions and stakeholders ask for substantiation. Teams accelerate review because the proof chain is explicit.

Output: Defensible claims
Claims Traceability by Polaris OS
Each value claim is linked to the evidence that supports it, down to the citation and the artifact behind it.
  • Source and version for every citation
  • Approval state per claim
  • Change history kept automatically
  • Gaps flagged before review
When a buyer, HTA body or reviewer asks for proof, the chain is already assembled and ready to share.
Traceable, Approved Claims
04.[ Package Module ]
Value Dossier & Proof Pack Engine

Value AI assembles market-ready dossiers from approved modules, aligned to value-based procurement and ESG scoring criteria, and bundles claims, evidence and governance status into audit-ready proof packs. Polaris enforces version control and permissions, so output stays consistent while localization stays fast.

Output: Submission-ready, defensible dossiers
Dossier Assembly by Polaris OS
Market-ready dossiers built from approved modules and adapted across countries and customer types without rewriting from scratch.
  • Requirements mapped to evidence
  • Value-based procurement criteria covered
  • ESG scoring gaps surfaced early
  • A standard response structure, reused
Claims, evidence, governance status and supporting documents in one submission-ready set, with approvals and change history captured, so you can defend what was submitted, when, and why.
Submission Ready — every claim traceable to its proof
Proof feeds the bid · Contract [RFx] AI
Request access

See Value AI in action.

A working session on your markets: your evidence baseline, the policy and HTA signals that affect it, and a dossier assembled with every claim traced to its proof.

Book A Demo ↗
White paper

AI-Powered Market Intelligence in MedTech Commercialization

How evidence, policy and market intelligence combine to strengthen market access and commercial decisions in MedTech.

Access White Paper ↗
The loop

Value AI proves the case. Pricing AI sets the position. Contract [RFx] AI wins it, with the proof attached.

Polaris Component

Contract [RFx] AI — Contract Execution Intelligence

Discovers, qualifies and responds to the opportunities your value story competes in. Traced claims and proof packs flow straight into the bid response.

Explore Contract [RFx] AI
Polaris Component

Pricing AI — Commercial Price Intelligence

Turns market signals, guardrails and scenarios into defensible prices, so the value you prove and the price you set tell the same story.

Explore Pricing AI
Why Vamstar
01

Domain Specialized

Deep expertise across medtech, pharma, and biotech, with intelligence shaped around the realities of complex lifescience markets.

02

Security Integrated

Dedicated local infrastructure, isolated deployments, and strong privacy controls ensure data stays protected within its designated jurisdiction.

03

Intelligently Powered

Built on Polaris, Vamstar turns fragmented data into operational intelligence for faster, more consistent decisions.

FAQ

Market access is the work of getting a product reimbursed, listed and bought in each market: building the value case, meeting health technology assessment (HTA) and policy requirements, and proving value in contracts. Value AI supports that work with a single evidence baseline, continuous policy and HTA tracking, traceable claims and submission-ready value dossiers.

Value-based procurement means buyers score bids on the value a product delivers, such as outcomes, total cost of care and sustainability, not on unit price alone. Value AI maps VBP and ESG scoring criteria to your evidence, surfaces gaps early and standardizes how you respond.

Every claim in a dossier or bid is linked to the evidence that supports it, with its source, version and approval state. If a buyer, reviewer or HTA body asks for substantiation, the proof chain is already assembled, and claims whose evidence is missing or out of date are flagged before submission.

No. Value AI does the gathering, tracking, linking and assembling so your team can spend its time on judgement. Claims, dossiers and proof packs carry approval states, and nothing is submitted without human sign-off.

View all FAQs

Insights

Research and perspectives on value, evidence and market access across pharma, biotech, and medtech.

Article

Agentic AI for Value and Market Access: Turning Evidence and Policy into a VBP Win Engine

How evidence and policy intelligence combine into a repeatable value-based procurement advantage.
Article

Orchestrating Commercial Excellence: Vamstar's Agentic AI

How agentic AI connects the commercial workflow end to end.
Article

Vertical AI Outperforms the Consulting Status Quo

Why domain-specific AI beats generic advisory for life-science commercial teams.
Article

Strategically Aligning Your MedTech Product Portfolio

Matching portfolio decisions to where value is recognized.
Article

Why Generic Software Will Fail at Price Optimization in Life Sciences

Contracts, reimbursement and reference pricing break tools built for catalogs.
Article

AI is About Transforming Human Ambition: Scaling What's Possible

What AI changes about what commercial teams can take on.